BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29778099)

  • 1. General practitioners can increase participation in cervical cancer screening - a model program in Hungary.
    Gyulai A; Nagy A; Pataki V; Tonté D; Ádány R; Vokó Z
    BMC Fam Pract; 2018 May; 19(1):67. PubMed ID: 29778099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of Participation in Organised Cervical Cancer-Screening Programme in Hungary.
    Gyulai A; Nagy A; Pataki V; Tonté D; Ádány R; Vokó Z
    Cent Eur J Public Health; 2015 Dec; 23(4):360-4. PubMed ID: 26841151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide screening program for breast and cervical cancers in Hungary: special challenges, outcomes, and the role of the primary care provider.
    Kolozsvári LR; Langmár Z; Rurik I
    Eur J Gynaecol Oncol; 2013; 34(5):419-24. PubMed ID: 24475575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based organized cervical cancer screening pilot program in France.
    Hamers FF; Duport N; Beltzer N
    Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and preliminary evaluation of the General Practitioners' Morbidity Sentinel Stations Program in Hungary. Prevalence of hypertension, diabetes mellitus and liver cirrhosis].
    Széles G; Vokó Z; Jenei T; Kardos L; Bajtay A; Hamburger I; Kósa Z; Pénzes M; Tokár Z; Paul Z; Papp E; Menyhárt I; Parragi K; Horváth G; Ertner S; Esenszki B; Fodor M; Molnár I; Lun K; Adány R
    Orv Hetil; 2003 Aug; 144(31):1521-9. PubMed ID: 14502866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an Intervention in General Practice to Increase the Participation of Immigrants in Cervical Cancer Screening: A Cluster Randomized Clinical Trial.
    Møen KA; Kumar B; Igland J; Diaz E
    JAMA Netw Open; 2020 Apr; 3(4):e201903. PubMed ID: 32236530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.
    Paulauskiene J; Ivanauskiene R; Skrodeniene E; Petkeviciene J
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500116
    [No Abstract]   [Full Text] [Related]  

  • 10. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
    Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
    J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Participation indicators of organized cervical cancer screening in Hungary].
    Vajda R; Bódis J; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Kívés Z; Boncz I
    Magy Onkol; 2022 Oct; 66(3):186-193. PubMed ID: 36200498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening uptake: A randomized controlled trial assessing the effect of sending invitation letters to non-adherent women combined with sending their general practitioners a list of their non-adherent patients (study protocol).
    Teigné D; Banaszuk AS; Grimault C; Abes L; Gaultier A; Rat C
    Front Public Health; 2022; 10():1035288. PubMed ID: 36438208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implementation status of cervical screening in Europe].
    Döbrőssy L; Cornides A; Kovács A; Budai A
    Orv Hetil; 2014 Dec; 155(50):1975-88. PubMed ID: 25481500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The coverage of cervical screening in Hungary].
    Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
    Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General practitioners who never perform Pap smear: the medical offer and the socio-economic context around their office could limit their involvement in cervical cancer screening.
    Maj C; Poncet L; Panjo H; Gautier A; Chauvin P; Menvielle G; Cadot E; Ringa V; Rigal L
    BMC Fam Pract; 2019 Aug; 20(1):114. PubMed ID: 31416425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective examination of the Hungarian breast and cervical cancer screening programmes according to mortality and morbidity data].
    Sárváry A; Bálint PC; Gyulai A; Kósa Z
    Orv Hetil; 2019 Dec; 160(49):1948-1956. PubMed ID: 31786940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities.
    Bao H; Wang L; Brown M; Zhang M; Hunt K; Di J; Zhao Z; Cong S; Fan J; Fang L; Wang L
    BMC Cancer; 2020 Dec; 20(1):1191. PubMed ID: 33276761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011).
    Vīberga I; Poljak M
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):27-30. PubMed ID: 23674182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Past, present and future of the cervical cancer screening in Latvia.
    Viberga I; Engele L; Baili P;
    Tumori; 2010; 96(4):529-37. PubMed ID: 20968131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.